SangStat To Sell Transplant Pharmacy To Chain Drug Store By Q1 2001
Executive Summary
SangStat expects to sell its specialty mail-order service, The Transplant Pharmacy, to a chain drug store by the end of the first quarter 2001.
You may also be interested in...
Failed Bioquivalence Studies Should Accompany ANDAs, FDA's Conner Says
FDA is considering issuing a guidance with instructions for ANDA sponsors on submitting failed bioequivalence studies.
Failed Bioquivalence Studies Should Accompany ANDAs, FDA's Conner Says
FDA is considering issuing a guidance with instructions for ANDA sponsors on submitting failed bioequivalence studies.
Abbott/SangStat May Launch Oral Solution Gengraf To Replace SangCya
SangStat and Abbott are considering launching Abbott's generic cyclosporine oral solution Gengraf following the July 10 recall of SangStat's cyclosporine SangCya, the companies said.